Search research articles
Contact Us
Filters
Showing results (31-40 of 244) with videos related to
Page
of 25
Sort By:
Annals of Medicine
|
August 1, 1996
Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus
I Juhan-Vague, M C Alessi, P Vague
The Journal of Laboratory and Clinical Medicine
|
February 1, 1983
Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay
D C Rijken, I Juhan-Vague, D Collen
Haemostasis
|
January 1, 1986
Natural inhibitors of fibrinolysis
I Juhan-Vague, M F Aillaud, A Serradimigni
Haemostasis
|
January 1, 1986
[Natural inhibitors of fibrinolysis]
I Juhan-Vague, M F Aillaud, A Serradimigni
Acta Chirurgica Scandinavica. Supplementum
|
January 1, 1982
Monitoring of fibrinolytic treatment with chromogenic substrate assays
I Juhan-Vague, M F Aillaud, G Chiche
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
March 8, 1981
[Erythrocyte deformability in diabetics. Effects of insulin. Relation to platelet aggregation]
I Juhan, P Vague, M Buonocore, et al.
Diabetologia
|
July 1, 1991
Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis
I Juhan-Vague, M C Alessi, P Vague
The Hematology Journal : the Official Journal of the European Haematology Association
|
June 11, 2004
Relations between hemostatic variables, insulin resistance and inflammation
Pierre E Morange, M C Alessi, I Juhan-Vague
Annales De Biologie Clinique
|
January 1, 1987
[Anti-activator inhibitors of plasminogen]
I Juhan-Vague, M C Alessi, M F Aillaud
Annals of Medicine
|
February 24, 2001
Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity
I Juhan-Vague, M C Alessi, P E Morange
Page
of 25
Search research articles
Search
Showing results (31-40 of 244) with videos related to
Sort By:
Page
of 25
Annals of Medicine
|
August 1, 1996
Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus
I Juhan-Vague, M C Alessi, P Vague
The Journal of Laboratory and Clinical Medicine
|
February 1, 1983
Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay
D C Rijken, I Juhan-Vague, D Collen
Haemostasis
|
January 1, 1986
Natural inhibitors of fibrinolysis
I Juhan-Vague, M F Aillaud, A Serradimigni
Haemostasis
|
January 1, 1986
[Natural inhibitors of fibrinolysis]
I Juhan-Vague, M F Aillaud, A Serradimigni
Acta Chirurgica Scandinavica. Supplementum
|
January 1, 1982
Monitoring of fibrinolytic treatment with chromogenic substrate assays
I Juhan-Vague, M F Aillaud, G Chiche
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|
March 8, 1981
[Erythrocyte deformability in diabetics. Effects of insulin. Relation to platelet aggregation]
I Juhan, P Vague, M Buonocore, et al.
Diabetologia
|
July 1, 1991
Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis
I Juhan-Vague, M C Alessi, P Vague
The Hematology Journal : the Official Journal of the European Haematology Association
|
June 11, 2004
Relations between hemostatic variables, insulin resistance and inflammation
Pierre E Morange, M C Alessi, I Juhan-Vague
Annales De Biologie Clinique
|
January 1, 1987
[Anti-activator inhibitors of plasminogen]
I Juhan-Vague, M C Alessi, M F Aillaud
Annals of Medicine
|
February 24, 2001
Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity
I Juhan-Vague, M C Alessi, P E Morange
Page
of 25